Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Cancers|March 25, 2022
Effect of Osimertinib on CTCs and ctDNA in EGFR Mutant Non-Small Cell Lung Cancer Patients: The Prognostic Relevance of Liquid BiopsyGalatea Kallergi, Emmanouil Kontopodis, Aliki Ntzifa, et al.
British Journal of Cancer|June 4, 2020
Phase 2 study of cabazitaxel as second-line treatment in patients with HER2-negative metastatic breast cancer previously treated with taxanes-a Hellenic Cooperative Oncology Group (HeCOG) TrialAngelos Koutras, Flora Zagouri, Georgia-Angeliki Koliou, et al.
Cancers|December 30, 2025
Real-World Neoadjuvant Systemic Therapy Utilization and Treatment Patterns in Patients with Early-Stage or Locally Advanced Triple-Negative Breast Cancer in Greece-The TRINITY StudyKonstantinos Papazisis, Christos Christodoulou, Flora Zagouri, et al.
Cancers|January 28, 2026
Combinatorial Analysis of CD4<sup>+</sup>Tregs, CD8<sup>+</sup>Teffs, and Inflammatory Indices Predict Response to ICI in ES-SCLC PatientsAnastasia Xagara, Konstantinos Tsapakidis, Vassileios Papadopoulos, et al.
Genomics|February 26, 2013
Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatmentDonghui Huang, Dong-Wan Kim, Athanasios Kotsakis, et al.
Journal of Cancer|June 16, 2023
Endobronchial Radiofrequency Ablation for pulmonary nodules with Radial-Ebus and Navigation: Pros and ConsPaul Zarogoulidis, Wolfgang Hohenforst-Schmidt, Wei Chen, et al.
BMC Cancer|July 3, 2026
Epidemiological trends of non-small cell lung cancer and systemic treatment rates as part of initial therapeutic strategy from 2016 to 2020 in Greece: results of the epidemiological part of INFINITY studySofia Agelaki, Stamatia Demiri, Athanasios Kotsakis, et al.
Anticancer Research|April 4, 2021
Evaluation of the Role of p95 HER2 Isoform in Trastuzumab Efficacy in Metastatic Breast CancerGeorgios Rigakos, Evangelia Razis, Georgia-Angeliki Koliou, et al.
Frontiers in Immunology|February 9, 2026
Immunophenotyping TCF1-expressing TILs: spatial profiling and prognostic value in operable non-small cell lung cancerKonstantinos Ntostoglou, Georgios Christodoulopoulos, Katie Stoker, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Front-Line Bevacizumab plus Chemotherapy with or without Maintenance Therapy for Metastatic Breast Cancer: An Observational Study by the Hellenic Oncology Research GroupStefania Kokkali, Emmanouil Saloustros, Dimitra Stefanou, et al.
Pageof 13